Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis eyes a new market with its buyout of a small digital therapeutics player
Endpoints
Mon, 04/20/20 - 10:51 am
Tags:
Novartis, M&A, Amblyotech, digital therapeutics, lazy eye
Incyte, Novartis launch drug study to treat coronavirus complication
Marketwatch
Sat, 04/18/20 - 11:22 pm
Tags:
Incyte, Novartis, cytokine storm, COVID-19, clinical trials, Jakafi
One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis
Endpoints
Wed, 04/15/20 - 10:39 am
Tags:
Novartis, drug discovery, solid tumors, immuno-oncology, Boston, startups, TScan
Eye drug side effects are real, Novartis confirms in new warning
BioPharma Dive
Thu, 04/9/20 - 11:15 pm
Tags:
Novartis, Beovu, side effects
Roche’s risdiplam delay a relief for SMA rivals Biogen and Novartis—for now: analyst
Fierce Pharma
Wed, 04/8/20 - 11:03 am
Tags:
Roche, FDA, risdiplam, Biogen, Spinraza, Novartis, Zolgensma, SMA
Former Novartis exec wants to repurpose generic drugs to fight Covid-19
Stat
Tue, 04/7/20 - 10:15 am
Tags:
Axcella Health, WHO, Novartis, generics, drug repurposing, COVID-19
AbbVie, Pfizer, Novartis and more pledge millions in COVID-19 disaster relief
Fierce Pharma
Mon, 04/6/20 - 09:36 pm
Tags:
COVID-19, pandemic, philanthropy, AbbVie, Pfizer, Novartis
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Thu, 04/2/20 - 10:49 am
Tags:
Novartis, generics, Sandoz, antitrust
No sanctions for Novartis as FDA ends review of gene therapy violations
BioSpace
Tue, 03/31/20 - 11:14 am
Tags:
Novartis, AveXis, Zolgensma, data manipulation
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy
Xconomy
Tue, 03/31/20 - 10:49 am
Tags:
SMA, Novartis, gene therapy, Zolgensma
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half
Fierce Biotech
Sat, 03/28/20 - 11:43 pm
Tags:
Novartis, ACC, PCSK9 inhibitors, inclisiran
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
Tags:
JNJ, Novartis, Boehringer Ingelheim, Biomerieux, Eisai, Eli Lilly, Gilead Sciences, GSK, Merck, Merck KGaA, Pfizer, Sanofi, R&D, COVID-19, diagnostics, vaccines
Novartis escapes one set of kickback allegations, but federal charges roll on
Fierce Pharma
Wed, 03/25/20 - 11:38 am
Tags:
Novartis, Gilenya, kickbacks, whistleblower lawsuits, ethics
In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug
Endpoints
Wed, 03/25/20 - 10:45 am
Tags:
Novartis, Merck KGaA, Japan, tepotinib, non-small cell lung cancer
Novartis publishes long-term data from SMA gene therapy
Pharmaforum
Tue, 03/24/20 - 10:31 am
Tags:
Novartis, Zolgensma, gene therapy, SMA
Novartis recalls immunosuppressant Sandimmune, Neoral capsules for hazardous packaging
Fierce Pharma
Thu, 03/19/20 - 11:35 pm
Tags:
Novartis, Sandimmune, Neoral, product recalls
Novartis posts pivotal data ahead of FDA decision on $9.7B bet
Fierce Biotech
Thu, 03/19/20 - 11:04 am
Tags:
Novartis, inclisiran, clinical trials, FDA
Novartis launches $20m COVID-19 response fund
PM Live
Wed, 03/18/20 - 10:33 am
Tags:
Novartis, COVID-19, grants, Public Health
New sickle cell drugs priced too high, ICER says
BioPharma Dive
Fri, 03/13/20 - 12:43 pm
Tags:
sickle cell disease, drug pricing, ICER, Novartis, Global Blood Therapeutics, RWE, Adakveo, Oxbryta
Novartis sidesteps Europe travel ban to provide CAR-T drug Kymriah to patients
Fierce Pharma
Fri, 03/13/20 - 12:41 pm
Tags:
Novartis, Europe, Donald Trump, gene therapy, Kymriah, COVID-19

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.